Research Pharmacy

研究药房

• 批准号: 8228404
• 负责人: Sylvia Bartel
• 金额: $ 22.58万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8228404
• 关键词: Cancer Center; Cancer Center Support Grant; Categories; Clinical Investigator; Clinical Research; Clinical Trials; Comprehensive Cancer Center; Dana-Farber Cancer Institute; Data; Drug Formulations; Ensure; Focus Groups; Fostering; Funding; Hospitals; Institution; Instruction; Investigation; Malignant Neoplasms; Monitor; Performance; Pharmaceutical Preparations; Pharmacists; Pharmacy facility; Physician Executives; Policies; Procedures; Process; Protocols documentation; Regulation; Reporting; Research; Research Personnel; Research Support; Resource Sharing; Review Committee; Safety; Site; System; Therapeutics Committee; Time; United States National Institutes of Health; Work; experience; meetings; member; operation; programs; quality assurance

PROJECT SUMMARY (See Instructions): The Research Pharmacy Core has a well-developed system for the monitoring, coordination, and support of research pharmacy activities at DF/HCC member institutions. This facility has been approved and funded by the CCSG since 2004, when it received excellent merit. The Core assures consistency in policies across the sites (including policies relating to the receipt, storage, formulation, and dispensation of investigational agents), facilitates best practices, and monitors performance through a quality assurance program coordinated through the inter-institutional Research Pharmacy Core Committee. The Research Pharmacy participates in the DF/HCC Scientific Review and Monitoring Committees (PRMS) and Data and Safety Monitoring (DSM) program, as well as other relevant Cancer Center clinical trials oversight, monitoring, and policy initiatives. Director: Sylvia Bartel, RPh, MHP Category: 4.03 (Research Pharmacy) Management: Cancer Center Managed

项目摘要（请参阅说明）： 研究药房核心具有一个完善的系统，用于在DF/HCC成员机构对研究药房活动的监测，协调和支持。自2004年以来，该设施已获得CCSG的批准和资助。核心确保了整个站点的政策的一致性（包括与收据，存储，配方和调查人员的分配有关的政策），促进最佳实践，并通过通过机构间研究药房核心核心委员会协调的质量保证计划来监视绩效。研究药房参加了DF/HCC科学审查和监测委员会（PRMS）以及数据与安全监控（DSM）计划，以及其他相关的癌症中心临床试验监督，监测和政策计划。 主任：Sylvia Bartel，RPH，MHP 类别：4.03（研究药房） 管理：癌症中心管理